Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 16, 2021 - Issue 12
Submit an article Journal homepage
16,133
Views
19
CrossRef citations to date
0
Altmetric
Editorial

How necessary are animal models for modern drug discovery?

Vijay K Singha Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA;b Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6631-3849View further author information
ORCID Icon &
Thomas M Seedc Tech Micro Services, Bethesda, MD, USAView further author information
Pages 1391-1397 | Received 29 Jun 2020, Accepted 06 Aug 2021, Published online: 03 Sep 2021

References

  • Singh VK, Hanlon BK, Santiago PT, et al. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with ‘standard of care’ medicinal and procedures not requiring regulatory approval for use. Int J Radiat Biol. 2017;93:885–906.
  • DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33.
  • Tanimoto T, Tsubokura M, Mori J, et al. Differences in drug approval processes of 3 regulatory agencies: a case study of gemtuzumab ozogamicin. Invest New Drugs. 2013;31(2):473–478.
  • Singh VK, Newman VL, Berg AN, et al. Animal models for acute radiation syndrome drug discovery. Expert Opin Drug Discov. 2015;10(5): 497–517.
  • McGonigle P, Ruggeri B. Animal models of human disease: challenges in enabling translation. Biochem Pharmacol. 2014;87(1):162–171.
  • Krumwieh D, Weinmann E, Siebold B, et al. Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys. Int J Cell Cloning 1990;8 Suppl 1: 229–248; discussion 47-8.
  • Singh VK, Seed TM. Entolimod as a radiation countermeasure for acute radiation syndrome. Drug Discov Today. 2021;26(1):17–30.
  • Capizzi RL, Oster W. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol. 2000;72:425–435.
  • Seyhan AA. Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles. Transl Med Commun. 2019;4(1):18.
  • Mak IW, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6:114–118.
  • Arrowsmith J. Trial watch: phase III and submission failures: 2007-2010. Nat Rev Drug Discov. 2011;10(2):87.
  • Arrowsmith J. Trial watch: phase II failures: 2008-2010. Nat Rev Drug Discov. 2011;10(5):328–329.
  • Denayer A, Rtohe T, Van Roy M. Animal models in translational medicine: validation and prediction. New HorizonTransl Med. 2014;2:5–11.
  • Lee H. Genetically engineered mouse models for drug development and preclinical trials. Biomol Ther (Seoul). 2014;22(4):267–274.
  • Naritomi Y, Sanoh S, Ohta S. Chimeric mice with humanized liver: application in drug metabolism and pharmacokinetics studies for drug discovery. Drug Metab Pharmacokinet. 2018;33(1):31–39.
  • Castellano JM, Palner M, Li SB, et al. In vivo assessment of behavioral recovery and circulatory exchange in the peritoneal parabiosis model. Sci Rep. 2016;6(1):29015.
  • Ito R, Takahashi T, Ito M. Humanized mouse models: application to human diseases. J Cell Physiol. 2018;233(5):3723–3728.
  • Aartsma-Rus A, van Putten M. The use of genetically humanized animal models for personalized medicine approaches. Dis Model Mech. 2019;13(2):dmm041673.
  • Bouabe H, Okkenhaug K. Gene targeting in mice: a review. Methods Mol Biol. 2013;1064:315–336.
  • Houdebine LM. Use of transgenic animals to improve human health and animal production. Reprod Domest Anim. 2005;40(4):269–281.
  • Scherma M, Giunti E, Fratta W, et al. Gene knockout animal models of depression, anxiety and obsessive compulsive disorders. Psychiatr Genet. 2019;29(5):191–199.
  • Leonova EI, Gainetdinov RR. CRISPR/Cas9 technology in translational biomedicine. Cell Physiol Biochem. 2020;54:354–370.
  • Food US, Administration D. Guidance document: product development under the animal rule. 2015. cited 2018 Oct 20 Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm399217.pdf
  • Swinney DC. Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin Pharmacol Ther. 2013;93(4):299–301.
  • Gintant GA, George CH. Introduction to biological complexity as a missing link in drug discovery. Expert Opin Drug Discov. 2018;13(8):753–763.
  • Singh VK, Seed TM, Olabisi AO. Drug discovery strategies for acute radiation syndrome. Expert Opin Drug Discov. 2019;14(7):701–715.
  • Vasaikar S, Bhatia P, Bhatia PG, et al. Complementary approaches to existing target based drug discovery for identifying novel drug targets. Biomedicines. 2016;4(4):27.
  • van der Worp HB, Howells DW, Sena ES, et al. Can animal models of disease reliably inform human studies? PLoS Med. 2010;7(3):e1000245.
  • Tickoo S, Russell S. Drosophila melanogaster as a model system for drug discovery and pathway screening. Curr Opin Pharmacol. 2002;2(5):555–560.
  • Artal-Sanz M, de Jong L, Tavernarakis N. Caenorhabditis elegans: a versatile platform for drug discovery. Biotechnol J. 2006;1(12):1405–1418.
  • Segalat L. Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem Biol. 2007;2(4):231–236.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.